It was always pie in the sky. The "big thinkers" at Magnis and c4v have no idea the risks and effort to get a consistent, state of the art, high volume, managed cost, battery cell product out to market. They never did. All that BS about ramping up to 1Gig production in year. They are dreaming. 1Gig is a huge effort and enterprise. Way beyond what the minnow could do.
Then there were all those warnings from Alevo to 123 etc. They were professional makers with deep pockets and expertise and they still went bust. Magnis were so cocky. They just kept digging themselves that big deep hole.
Watch out punters
DYOR
- Forums
- ASX - By Stock
- MNS
- The pros and cons of MNS.
The pros and cons of MNS., page-99
-
- There are more pages in this discussion • 977 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MNS (ASX) to my watchlist
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.37M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MNS (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online